AbbVie
ABBV
#33
Rank
$367.24 B
Marketcap
$207.86
Share price
2.51%
Change (1 day)
10.31%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): $6.59 Billion USD

According to AbbVie's latest financial reports the company's current earnings are $61.16 Billion USD. , an increase over its 2024 earnings that were of $3.71 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 $6.59 B77.53%
2024 $3.71 B-40.54%
2023 $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.12 B 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.08 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.62 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$9.79 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.59 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$14.66 B 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$10.01 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.79 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA